It's a shame, that each and everyone has become to
Post# of 148164
We we're doing great regarding HIV and cancer.
It looks like everything has been dropped for Covid-19.
Not filing BLA as promised is a huge mistake. Unneccessary as since january/february the filing has always been days away.
Now we've attracted mostly new investors that are in it for Covid-19.
I feel we're going to miss the boat there. Not because of the product, but because of we just don't have the resources BP has.
Doctors are too busy to pay attention to some doctor in NY or Florida having good results with Leronlimab.
They're going to chose/try what they do hear and that's just what BP promotes.
I feel we're wasting valuable time and money on something that will never be.
Not advocating to leave patients in the cold, but just don't put anymore effort in it. Don't use our scarse resources for a lost cause.
Just finish the BLA trial. Get Jonah Sacha's results published. Work on Prep. Basket trial? No use as long as we're in the CV shit. Vulnerable people avoid going to hospitals if they don't have to. Clinical trials means more hospital contacts. Thus, people avoid that.